Migraine sufferers continue to urge for improved recognition and treatment of the condition, emphasizing that migraines are more than just severe headaches. The disorder is increasingly understood as a complex neurological event involving a range of symptoms beyond head pain, which can significantly impair daily functioning.

One affected individual highlighted that prior to perimenopause, her migraines manifested primarily through symptoms such as profound fatigue, body aches, and cognitive difficulties—symptoms often underestimated or misattributed by healthcare providers. These manifestations, which can occur even before headache onset, contributed to a delayed diagnosis, as her condition was mistaken for immune system issues rather than a neurological disorder.

Experts and patients alike note that migraine management remains challenging due to factors beyond individuals’ control, particularly hormonal changes experienced during puberty, reproductive years, and perimenopause. Women may experience cyclical migraine attacks linked to menstruation and ovulation, and in some cases, attacks can persist for significantly prolonged periods. During perimenopause, daily hormonal fluctuations may lower the nervous system's threshold for migraine occurrence, leading to nearly continuous symptoms including overlapping prodrome and postdrome phases.

The complexity of migraine’s hormonal influences underscores the view that treatment approaches should extend beyond neurology. Despite the critical role of hormonal triggers, many gynecologists lack specialized understanding of migraine's neurological aspects, and some perimenopausal treatments may inadvertently exacerbate symptoms.

Regarding therapeutic options, advances such as the introduction of gepants have been hailed as transformative for some patients. General practitioners now have the ability to prescribe Rimegepant for those who do not respond well to triptans, offering new avenues for relief. However, access to these medications varies regionally, creating disparities in treatment availability.

Advocates stress that recognizing migraine as a genetic, multisystem condition — notably affecting women disproportionately — is essential to overcoming ongoing dismissal and under-treatment. They call for a more integrated medical approach that addresses the full spectrum of migraine symptoms and their underlying causes to improve outcomes for sufferers.